Â鶹ÊÓƵ

Fears about the erosion of future revenues as patents expire have weighed on Merck’s valuation

Investors are being paid to wait for a recovery in sentiment towards this energy efficiency trust

Conservative revenue recognition policies mean it is bringing in more cash than its bottom line suggests

Two years of tough trading shouldn’t detract from the strong long-term fundamentals

It already has a globalised footprint and huge market share – moves that could soon pay off

A short-term slowdown in orders does not detract from the investment case

This fund is comfortably beating the global stock market index without relying on one single country, setting it apart from its peers

The African producer is in a temporary fallow period, but the share price has fallen too far

The group is outshining rivals, with industry-leading margins and a model fit for tougher times

End markets have been volatile, but the opportunity is clear